<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref108">
 <label>[108]</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Nenna</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Nappi</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Avtaar Singh</surname>
   <given-names>SS</given-names>
  </string-name>, 
  <string-name>
   <surname>Sutherland</surname>
   <given-names>FW</given-names>
  </string-name>, 
  <string-name>
   <surname>Di Domenico</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Chello</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Spadaccio</surname>
   <given-names>C</given-names>
  </string-name> (
  <year>2015</year>) 
  <article-title>Pharmacologic approaches against advanced glycation end products (AGEs) in diabetic cardiovascular disease</article-title>. 
  <source>Res Cardiovasc Med</source>
  <volume>4</volume>, 
  <fpage>e26949</fpage>.
  <pub-id pub-id-type="pmid">26393232</pub-id>
 </mixed-citation>
</ref>
